Annual Report & Accounts 2026
47
OUR FINANCIALS
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME YEAR ENDED 31 JANUARY 2026
Note
2026 £ 2026 £ Revenue
4
115,168,827
97,703,149
Cost of sales
(85,819,172)
(72,229,270)
Gross profit
29,349,655
25,473,879
Trade receivables impairment
17
(1,774,951)
(1,470,788)
Corresponding reduction in trade payables
17
1,266,897
1,065,268
(508,054)
(405,520)
Depreciation and amortisation
5
(691,074)
(823,681)
Share-based payments
5
(851,320)
(780,662)
Other administrative expenses
5
(15,307,968)
(12,940,290)
Gain in respect of investments held at fair value
16
184,388
–
Other operating income
87,935
50,070
Operating profit
6
12,263,562
10,573,796
Finance income
7
3,196,726
1,966,246
Financing costs
7
(788,676)
(855,043)
Profit before tax
14,671,612
11,684,999
Taxation
11
(3,611,636)
(3,135,226)
Profit and total comprehensive income for the year attributable to equity holders of the Parent
11,059,976
8,549,773
Basic EPS (p)
12
34.9
27.1
Diluted EPS (p)
12
34.3
26.6
The above results were derived from continuing operations.
OUR FINANCIALS
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME YEAR ENDED 31 JANUARY 2026
Note
2026 £ 2026 £ Revenue
4
115,168,827
97,703,149
Cost of sales
(85,819,172)
(72,229,270)
Gross profit
29,349,655
25,473,879
Trade receivables impairment
17
(1,774,951)
(1,470,788)
Corresponding reduction in trade payables
17
1,266,897
1,065,268
(508,054)
(405,520)
Depreciation and amortisation
5
(691,074)
(823,681)
Share-based payments
5
(851,320)
(780,662)
Other administrative expenses
5
(15,307,968)
(12,940,290)
Gain in respect of investments held at fair value
16
184,388
–
Other operating income
87,935
50,070
Operating profit
6
12,263,562
10,573,796
Finance income
7
3,196,726
1,966,246
Financing costs
7
(788,676)
(855,043)
Profit before tax
14,671,612
11,684,999
Taxation
11
(3,611,636)
(3,135,226)
Profit and total comprehensive income for the year attributable to equity holders of the Parent
11,059,976
8,549,773
Basic EPS (p)
12
34.9
27.1
Diluted EPS (p)
12
34.3
26.6
The above results were derived from continuing operations.